Outbreaks of methylmercury poisoning in Japan and Iraq have demonstrated the sensitivity of the fetus to neurotoxic effects. Based on toxicokinetics and considerations of practicability, the optimal biomarker of methylmercury exposure is the hair concentration, but whole-blood measurements of mercury are also useful. Dose-response relations are still incompletely known, especially concerning developmental neurotoxicity under conditions of chronic exposure. Available evidence indicates that neurobehavioral dysfunction in children may occur if the maternal mercury concentration in hair is >6 pg/g (30 nmol/g). This value corresponds to a blood mercury concentration of -24 pgIL (120 nmol/L). The period of maximum sensitivity of the nervous system to methylmercury toxicity is unknown, but the transfer of mercury to the newborn through human milk may represent an additional risk. In view of the wide occurrence of mercury contamination in developing countries, increased use of the exposure biomarkers is encouraged. 
(1).
In infants the disease was often not recognized until at least 3 months after birth, at a time when the child was still being nursed. However, a surprising observation was that many of the mothers appeared healthy (1).
Could toxic amounts of a chemical be transferred across the placenta or into human milk? These were controversial notions in the 1950s.
Other research has documented that the nervous system is particularly vulnerable to toxic effects from environmental toxicants during the last two trimesters of pregnancy and during early postnatal life (2). Experimental studies have also shown that methylmercury can pass the placental barrier and result in even higher concentrations in the fetus than in the mother (3).
Serious poisonings
have also occurred as a result of the accidental use of methylniercury-treated seed to make bread, e.g., in Iraq (4). In addition, methylmercury is a widespread pollutant that is a health hazard to large population groups that rely on seafood. The clinical and epidemiological information from the unfortunate poisoning episodes (1, 4) should therefore be utilized to design strategies to prevent toxic exposures to this compound. In this regard, biomarkers of methylmercury exposure are likely to play a key role.
Choice of Exposure Markers
Several detection methods are available for measuring mercury and its compounds in biological media (5).
Therefore, the optimal exposure marker can be chosen on the basis of toxicokinetics and consideration of practicality.
Methylmercury becomes distributed relatively evenly in the body, and short-term elimination of the compound approximates to simple first-order kinetics (6). While urinary mercury excretion is a good indicator of exposure to inorganic mercury, it does not reflect exposure to methylmercury.
In this case, the most useful samples for analysis are likely to be hair and blood.
Laboratory animal studies involving tracer techniques have shown that, following acute dosage with methylmercuiy, blood mercury concentrations will initially reflect organ concentrations reasonably well, but, with time, an increasing fraction of the body burden will be in the brain, muscles, and kidney. Also, the concentration of total mercury in the blood, and especially in serum, is affected by exposure to elemental mercury and inorganic mercury compounds. In populations exposed mainly to methylmercury, account must be taken of the fact that umbilical cord blood contains 20%-30% higher concentrations of mercury than does maternal blood (6 between the three groups. Because the diagnostic criteria were not described in the published paper, the extent of possible misclassification is difficult to assess.
To relate these cord concentrations to more useful hair mercury concentrations, a correlation has been established between the total mercury concentrations in the two types of samples Mercury concentrations in human milk correspond to -8% of the concentration in whole blood (4, 14) , but some of the mercury occurs in the form of mercuric ion, in particular when exposure to inorganic mercury has occurred (15).
In Iraq human milk was the suspected source of methylmercury exposure of several infants who developed symptoms of methyhnercury poisoning during the nursing period (14).
Early Effects
For preventive purposes, documentation should be obtained to identify the methyhnercury exposure concentration that causes the earliest adverse effects. By keeping human exposures below that threshold, the population (or some statistically defined large proportion) will be protected against toxicity. With methylmercury, the difficult task is to determine the exact character of such early dysfunctions and then to assess per week, i.e., -30 g (150 nmol) per day, would, at steady state, result in a blood mercury concentration of 24 pg/L (120 nmol/L) or a hair mercury concentration of -6 g/g (30 nmollg). These values are well below the concentrations associated with clinical effects in adults. However, considering the aforementioned uncertainties and the fact that, for example, the high exposure group in the New Zealand study had maternal hair mercury concentrations >6 p.g/g (30 nmollg) (23, 24) , the safety margin offered by the PTWI for prenatal exposures could be very slim.
While recognizing the uncertainties, the PTWI can also be translated into an approximate limit for mercury in human milk. If the standard adult person weighs 70 kg, the PTWI corresponds to a daily dose of -0.6 pg (3 nmol) mercury per kg body weight. For infants, the average milk intake during the nursing period is -125 mL(kg body weight per day (27). An intake corresponding to the PTWI on a per kilogram basis would then occur if the milk mercury concentration were 4.8 gfL (24 nmol/L). 
Current Extent of the Problem

Strategy for Use of Biomarkers
In each situation, the proper choice of an exposure biomarker must be based on all available information about the sources of exposure, the route of entry, the mercury speciation, and the population at risk. Practical considerations, cost, and ethical constraints must be considered as well.
Often, scalp hair samples will be the preferred type of specimen, in so far as the collection procedure is noninvasive and storage and transportation present limited problems. These advantages are especially important in developing countries where other biological samples may be subject to decomposition before they reach the analytical laboratory. Following oral exposure, the hair mercury concentration is generally taken to reflect the body burden of methylmercury (6) . However, as exogenous contamination of the hair may occur, e.g., from mercury vapor, and as scalp hair is not always available from the subjects, other samples may need to be considered. (In some cases, pubic or other body hair has been used for analysis.) A particular disadvantage is that a hair sample will not reflect a recent increased exposure.
Hair samples should include full-length hair strands cut with a pair of sharp scissors close to the root in the occipital area of the scalp. For most methods, the samples should preferably weigh at least 100 mg, this size would also allow segmental analysis by some methods. The hair should be tied close to the root with a cotton string or plastic clamp and saved in a marked plastic bag. (38) have been very useful and ought to be organized on a more permanent basis.
